189 related articles for article (PubMed ID: 1721317)
21. Chymotryptic-type protease inhibitors block the increase in Ca2+ and Il-2 production in activated Jurkat T cells.
Auberger P; Mary D; Breittmayer JP; Aussel C; Fehlmann M
J Immunol; 1989 Feb; 142(4):1253-9. PubMed ID: 2521661
[TBL] [Abstract][Full Text] [Related]
22. The interaction of immunosuppressive compounds in tandem stimulated peripheral human lymphocytes.
Weaver JL; Pine PS; Aszalos A
Immunopharmacol Immunotoxicol; 1994 May; 16(2):179-90. PubMed ID: 7521360
[TBL] [Abstract][Full Text] [Related]
23. The inhibition of T-cell-receptor-induced Fas ligand upregulation by cyclosporine and FK 506.
Nakajima H; Oka T
Transplant Proc; 1996 Apr; 28(2):1052-5. PubMed ID: 8623224
[No Abstract] [Full Text] [Related]
24. Effect of 15-deoxyspergualine on antigen-specific lymphocyte activation measured by CD69 expression.
Maitre N; Goust JM
Clin Immunol Immunopathol; 1997 Oct; 85(1):109-11. PubMed ID: 9325077
[No Abstract] [Full Text] [Related]
25. Stimulatory roles of muscarinic acetylcholine receptors on T cell antigen receptor/CD3 complex-mediated interleukin-2 production in human peripheral blood lymphocytes.
Fujino H; Kitamura Y; Yada T; Uehara T; Nomura Y
Mol Pharmacol; 1997 Jun; 51(6):1007-14. PubMed ID: 9187267
[TBL] [Abstract][Full Text] [Related]
26. Heterogeneity of dialysis patient lymphocyte responses to cyclosporine.
Briggs WA; Gao ZH; Xing JJ; Scheel PJ; Gimenez LF; Burdick JF
Transplant Proc; 1996 Aug; 28(4):2063-5. PubMed ID: 8769157
[No Abstract] [Full Text] [Related]
27. The effects of FK-506 and cyclosporin A on the proliferation of PHA-stimulated T cells in response to IL-2, IL-4 or IL-6.
Liu J; Sakane T; Tsunematsu T
Int Arch Allergy Immunol; 1992; 98(4):293-8. PubMed ID: 1384862
[TBL] [Abstract][Full Text] [Related]
28. Immune monitoring after renal transplantation. II. Post-transplant disturbances in the CD3 complex expression may be caused by immunosuppression.
Nowaczyk M; Górski A; Małdyk M; Juskowa J; Wyzgal J; Modlińska M; Bukowska J; Morzycka-Michalik M
Arch Immunol Ther Exp (Warsz); 1991; 39(3):297-9. PubMed ID: 1839763
[TBL] [Abstract][Full Text] [Related]
29. Effect of FK 506 and cyclosporine on the expression of IL-6 and its receptor on stimulated monocytes.
Moutabarrik A; Takahara S; Namiki M; Kokado Y; Seguchi T; Yokokawa K; Takano Y; Zaid D; Ishibashi M; Okuyama A
Transplant Proc; 1993 Jun; 25(3):2320-1. PubMed ID: 7685949
[No Abstract] [Full Text] [Related]
30. Effects of FK 506 and cyclosporine on T-cell activation: integrin-mediated adhesion of T cells, proliferation, and maturation of cytotoxic T cells.
Eiras G; Shimizu Y; van Seventer GA; Duquesnoy RJ; Zeevi A
Transplant Proc; 1991 Feb; 23(1 Pt 2):936-9. PubMed ID: 1703357
[No Abstract] [Full Text] [Related]
31. New approach in drug development: whole blood pharmacodynamic assays reflect biological activities of tacrolimus.
Klupp J; Dambrin C; Regieli J; van Gelder T; Shorthouse R; Morris RE
Transplant Proc; 2001 May; 33(3):2172. PubMed ID: 11377491
[No Abstract] [Full Text] [Related]
32. Inhibition of apoptosis in anti-CD3-treated peripheral blood lymphocytes by immunosuppressive drugs.
Vathsala A; Chin YM; Noraiza I; Sun L
Transplant Proc; 2000 Nov; 32(7):1992-4. PubMed ID: 11120034
[No Abstract] [Full Text] [Related]
33. The effect of the immunosuppressant FK-506 on alternate pathways of T cell activation.
Bierer BE; Schreiber SL; Burakoff SJ
Eur J Immunol; 1991 Feb; 21(2):439-45. PubMed ID: 1705513
[TBL] [Abstract][Full Text] [Related]
34. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice.
Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z
Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism.
Dayton JS; Turka LA; Thompson CB; Mitchell BS
Mol Pharmacol; 1992 Apr; 41(4):671-6. PubMed ID: 1569921
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506.
Kay JE; Benzie CR; Goodier MR; Wick CJ; Doe SE
Immunology; 1989 Aug; 67(4):473-7. PubMed ID: 2475433
[TBL] [Abstract][Full Text] [Related]
37. Effects of combined administration of FK 506 and the purine biosynthesis inhibitors mizoribine or mycophenolic acid on lymphocyte DNA synthesis and T cell activation molecule expression in human mixed lymphocyte cultures.
Thomson AW; Woo J; Yao GZ; Todo S; Starzl TE; Zeevi A
Transpl Immunol; 1993; 1(2):146-50. PubMed ID: 7521738
[TBL] [Abstract][Full Text] [Related]
38. Effects of FK 506 and low concentration cyclosporine on human lymphocyte activation antigen expression: a flow cytometric analysis.
Woo J; Sewell HF; Thomson AW
Transplant Proc; 1990 Aug; 22(4):1645-6. PubMed ID: 1697113
[No Abstract] [Full Text] [Related]
39. UVB irradiation of human-derived peripheral blood lymphocytes induces apoptosis but not T-cell anergy: additive effects with various immunosuppressive agents.
Yaron I; Yaron R; Oluwole SF; Hardy MA
Cell Immunol; 1996 Mar; 168(2):258-66. PubMed ID: 8640873
[TBL] [Abstract][Full Text] [Related]
40. Development of a macromolecular prodrug of FK 506: II: In vitro study for FK 506-dextran conjugate.
Yura H; Yoshimura N; Hamashima T; Oka T; Takakura Y; Hashida M
Transplant Proc; 1998 Jun; 30(4):1031-2. PubMed ID: 9636416
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
